Summary
Mymetics Corp (Mymetics) is a development stage biotechnology company which develops next-generation prophylactic vaccines for infectious diseases. It develops mucosal and virosomes based vaccines that help prevent HIV (AIDS) from crossing the mucosal barriers; malaria; respiratory syncytial virus (RSV); and influenza. Its vaccines are designed to induce protection against early transmission and infection. The company's product pipeline includes five vaccine candidates target HIV-1/AIDS, intra nasal Influenza, malaria, herpes simplex virus (HSV) and respiratory syncitial virus (RSV). The company and its subsidiaries have operations across Luxembourg, the US, Netherlands, and Switzerland. The company has partnerships with leading pharmaceutical or research organizations, including Astellas Pharma, PATH-MVI and the Bill and Melinda Gates Foundation. Mymetics is headquartered in Epalinges, Switzerland.
Mymetics Corp (MYMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mymetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mymetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mymetics Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mymetics Enters into Research Agreement with Sanofi 10
Mymetics Enters into Co-Development Agreement with Path Malaria Vaccine Initiative 10
Licensing Agreements 11
RSV to Terminate Licensing Agreement with Mymetics for Respiratory Syncytial Virus Vaccine 11
Mymetics Corp - Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16List of Tables
Mymetics Corp, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mymetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mymetics Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Mymetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Mymetics Enters into Research Agreement with Sanofi 10
Mymetics Enters into Co-Development Agreement with Path Malaria Vaccine Initiative 10
RSV to Terminate Licensing Agreement with Mymetics for Respiratory Syncytial Virus Vaccine 11
Mymetics Corp, Key Competitors 13
Mymetics Corp, Key Employees 14
Mymetics Corp, Subsidiaries 15List of Figures
Mymetics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mymetics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
